posted
we all get stuck... but your not stuck siri is a good stock and will be great in the long haul. the greatest trick is not selling its difficult. just hang in there with your ncdp. and in feb take what ever disposable income you have and buy on the next low. do that for the next 2 or 3 months and then there will be a great news release and it will spike.
IP: Logged |
posted
Here's some updates. I e-mailed David Donlin at Cervelle. My e-mail and then his answers:
Hey Dave,
Just asking for some more information.
1. Can you tell me how many authorized shares there are and what is the current float? Also, is there any information as to the & breakdown of what insiders hold, institutions, retailers, etc.?
2. Are any of the clinical studies on the effectiveness of Nicodrops available to peruse? If not, is there any proof (besides testimonials) as of today that the product is effective?
3. Chris had mentioned in earlier press releases that a sugar free lozenge was available, however, none of us have seen the product in CVS or offered at nicodrops.com . Is the sugar free lozenge available, or merely something to be released in the near future?
4. Do you know if the auditing of the firm's financials have begun to prepare for OTCBB listing?
Thanks again, and look forward to the next big press release!
Regarding your most recent inquiry here is what I know……
I’m not sure about the authorized nor the outstanding or float. I’m guessing the authorized is somewhere upwards toward a billion but let me say this is not confirmed…I think there is a filing that can be checked in this matter. We are still trying to get a confirmation from the company on out and float. I think the out is atleast 400 million and float is atleast 100 million but please keep in mind these numbers are not definitive.
I don’t believe there any clinical studies that would be viewed as legitimate due to their nature and scope. I do know the company has been receiving a number of testimonials on the effectiveness of the product.
I will check with Chris on the sugar free lozenge…I think CVS only wanted the regular product since it is only being offered on a trial basis at this time.
The auditing of NCDPs financials have not begun yet. This process is costly and I would imagine that the company would be more inclined to generate more sales at this time giving them the flexibility they need to take the company to the next level – fully reporting and OTC BB listing.
Also, after meeting with Chris two weeks ago in California I can tell you that they are continuing to execute their business plan which includes other distribution channels and marketing prospects in Europe as well as Asia before the year is over.
posted
Gotta relax guys and gals....it will take a minimum of 6 months for anything to really happen, IMO. Takes a lot of sales work, manufacturing, and time to make a major company.
-------------------- If I give you bad information, please feel free to sue me. I have nothing left anyway. Ed
IP: Logged |
posted
Don't be worried about lack of PR's... a lot of PR's usually equals fluff PR's. Read the correspondence above. They are doing their work. Let Joel Appel work... and good things will happen.
All we have to be concerned with right now is to make sure that the product works. Period. And according to all testimonials I've read, it does.
IP: Logged |
I disagree with the notion that Nicodrops will gain a foothold in the US anytime this year with the actions or lack there of-Chris and Joel are taking. Advertising should have started alongside of distribution thru CVS such as "Nicodrops coming to a store near you" etc.etc.-I am holding but getting disgruntled and not pumping this stock anymore. If Chris and Joel think they can take on Glaxo and other big muscle pharmas-they are sadly diluted.What happended to Joel's skill and smarts in PR and advertising? Give him time right-he already screwed the pooch man-distribution without advertising is a death knoll.
IP: Logged |
posted
Well if you disagree, then feel free to disagree. I agree - ideally, advertising, distribution, and manufacturing should have all been together. My personal opinion - Chris is not the expert in Marketing. And he jumped the gun on the CVS deal. That's why now, we haven't heard boo. Joel is probably making sure that Quigley starts manufacturing enough for distribution to the 3 or 4 more stores that Joel is hoping to sign. And he won't start distributing again until he marketing campaign is ready. So yes, it could be months before we see a solid PR. But I have faith.
And besides, if Glaxo is threatened, they could buy out NCDP for negligible amounts of money (what's the market cap - $6 mil?), but would be a nice return for us shareholders.
IP: Logged |
posted
Namoper: IMO Glaxo is not threatened at all. The pharmacist at CVS said they genrally recommend the Nicoderm patch to people trying to quit. He hadn't even heard of Nicodrops. That is my point, Joel moving too slow with advertising-why? because they have no money. Maybe next year. This is a very long term hold IMO.
IP: Logged |
posted
i guess with the drop in the pps its time to stock up! i still have not found this in my are CVS stores. would really like to see the product and test it myself...but will have to wait. still holding...glad i sold of most of my mlon at .0018 to buy ncdp!!!
IP: Logged |
posted
Nice big block buy went through his morning. Seems to me that the PPS will move upward quickly once a PR is released... everyone seems to be holding strong for at least .1, if not .2
IP: Logged |
GSK Consumer Healthcare Launches Suit to Stop Misleading Marketing of Unproven Herbal Smoking Cessation Therapy Tuesday February 8, 3:55 pm ET - GlaxoSmithKline Calls for End to False Promises to Smokers Looking to Quit -
PITTSBURGH, Feb. 8 /PRNewswire/ -- GlaxoSmithKline (GSK) Consumer Healthcare filed suit today in Federal district court to seek an injunction against Nicodrops, Inc., the maker of Nicodrops, for false claims relating to the safety and efficacy of its so-called smoking cessation system. There is no proof that any herbal ingredient in Nicodrops, or the Nicodrops product itself, is a safe or effective therapy for smoking cessation, yet the company is making safety and efficacy claims.(1) Nicodrops and any other products making health claims as a drug should be subject to the same, rigorous FDA review process as GSK Consumer Healthcare's nicotine replacement therapies, which are proven to help smokers quit. GSK Consumer Healthcare has a long history in developing innovative smoking cessation products, and currently sells the broadest range of non- prescription FDA-approved methods, including NicoDerm CQ(R) patch, Nicorette(R) gum, and Commit(R) lozenge. "Quitting smoking is one of the most important steps smokers can take to improve their health, but it's very hard to do," said George Quesnelle, President, GSK Consumer Healthcare, North America. "GlaxoSmithKline Consumer Healthcare is in this business to help people quit smoking, and we've invested decades of work and considerable financial resources to ensure that our products are safe and are proven to work. Smoking is the number one preventable cause of disease and death in this country. When people are misled into using snake oil instead of products that are proven to work, they waste a critical opportunity to quit smoking and potentially save their own lives."
The complaint addresses specific and false information about GSK Consumer Healthcare's products published by Nicodrops, and seeks immediate retraction. "Unproven products making unsubstantiated claims of superiority over FDA- approved smoking cessation therapies puts smokers at risk," said Quesnelle. "We simply want Nicodrops to stop making false claims about their products and ours, and to withdraw their products from the marketplace until they can market them truthfully."
To date, GSK Consumer Healthcare's stop-smoking products have helped more than 2 million Americans stop smoking by providing lower, safe doses of nicotine to ease withdrawal from cigarettes. GSK Consumer Healthcare's nicotine replacement therapy (NRT) products are clinically proven to help smokers safely manage the symptoms of nicotine dependence and withdrawal so they can quit successfully.(2) NRT helps smokers quit without exposing them to the more than 4,000 chemicals and at least 69 known or suspected carcinogens found in tobacco smoke.(3) Smokers can choose which medicinal nicotine product to use based upon their preferences and individual smoking habits, including how much they smoke. Further, smokers can choose a GSK Consumer Healthcare medication confident in the knowledge that these products have been tested in over 100 controlled clinical trials involving over 35,000 participants and found to be safe and effective in helping smokers quit.(4)
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over- the-counter healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette and NicoDerm and Commit, as well as many medicine cabinet staples, Abreva(R), Aquafresh(R), Sensodyne(R) and Tums(R). GSK Consumer Healthcare continues to develop innovative products to help all smokers find their best support system and achieve their goal of being cigarette free.
About GlaxoSmithKline
GlaxoSmithKline is one of the world's leading research-based pharmaceutical and consumer healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
IP: Logged |
posted
GSK doesnt want the competition... understandable. this will probably have a neg effect on the pps. DAMN!! but if the product works--NCDP will have to back up their claims. maybe its a scare tactic
Think about it for a second. Glaxo is a multi-billion dollar pharm company. There are over 70+ products (gums, pills, water, drops, etc.) that claim to help smokers quit. Yet, Glaxo targets a start up PINK SHEET company with no advertising, one retailer on a trial basis, no brand awareness, no financials, nothing. Why? Other herbal remedies do exist out there, yet they target NCDP. Why? Because they really think there is a public health risk by taking Nicodrops??
C'mon folks. They are scared. Pharms always try to crush competition. They know something - either they know about another major retailer being signed, or about an ad campaign to kick off, or about current sales... they know something and are afraid.
The stock was up today, and spiked at the end of day. Why in God's name would anyone sell now??? PPS may dip, but that's it. Most shareholders will hold and wait for a response from Chris. If he can prove that Nicodrops works from independent 3rd party testimonials, AND prove that no side effects occur, we are looking at THE stock of 2005.
IP: Logged |
posted
i will hold--youre right about that--just hope the thousands of people in this agree.why would anyone sell now? well they might sell for any number of reasons, but most likely because of this pr. when NCDP does come out with a pr to defend itself, then we will see. and a pr would be about time. i cant remember when the last one was, but i think around dec 16?
posted
I think I will buy more as the few that get scared get out. Once this suit is resolved I believe that we will have the proof needeed to boost our pps skyward. How long do these types of suits last? I just want to know how much time I have to accumulate. It is a gamble, what the court decides will determine the future of this company, and I'm feeling lucky........
posted
Who the hell died and made these glaxosmithkline idiots the watch dog over us anyway. I see this as a very, very positive pr. Apparently this stuff has them worried otherwise why waste their time. Think I'll switch from Tums to Rolaids, Aquafresh to Colgate and if I can find any additional products they make, I'll stop using them too.
They certainly have done all NCDP stockholders a favor as I see it.
Dakota told you that......
-------------------- Dakota Just because I'm paranoid don't mean there ain't someone behind me........
IP: Logged |
posted
I just read the PR again. This is not a new issue, drug companys have been trying to get herbal remedys under the same rigerous testing that their products go through in testing by the FDA. I am going to search for other cases that have similar suits "false claims relating to the safety and efficacy of a herbal product". I suggest that others do the same. I will report back later.....
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Razz]](tongue.gif)
